MEDCast cover art

MEDCast

MEDCast

By: MJH Life Sciences
Listen for free

About this listen

 MEDCast is a healthcare program brought to you by HCPLive.com that features leading medical experts who discuss a range topic within a particular condition or medical disorder.© Biological Sciences Hygiene & Healthy Living Nature & Ecology Physical Illness & Disease Science
Episodes
  • Empowering Pharmacists in the Management of Patients With Urothelial Cancer

    Empowering Pharmacists in the Management of Patients With Urothelial Cancer
    Sep 3 2025
    Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients with bladder cancer through treatment selection, patient education, adverse effect monitoring, and the evolving landscape of therapies including traditional chemotherapy, immunotherapy, and antibody-drug conjugates like enfortumab vedotin plus pembrolizumab.
    Show More Show Less
    46 mins
  • Personalizing Progress: New Data Shaping Care in Central Precocious Puberty

    Personalizing Progress: New Data Shaping Care in Central Precocious Puberty
    Aug 29 2025
    Panelists discuss how central precocious puberty involves early activation of the hypothalamic-pituitary-gonadal axis before age 8 in girls and age 9 in boys, requiring individualized treatment decisions based on factors like growth velocity, bone age advancement, and psychosocial impact, with GnRH agonist therapies available in multiple formulations (injections and implants) that effectively suppress puberty while preserving final height potential and having reassuring long-term safety profiles for bone health and fertility outcomes.
    Show More Show Less
    43 mins
  • Empowering Pharmacists in the Management of Patients With Urothelial Cancer

    Empowering Pharmacists in the Management of Patients With Urothelial Cancer
    Aug 27 2025
    Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients with bladder cancer through treatment selection, patient education, adverse effect monitoring, and the evolving landscape of therapies including traditional chemotherapy, immunotherapy, and antibody-drug conjugates like enfortumab vedotin plus pembrolizumab.
    Show More Show Less
    47 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.